Sign in

CIK 0001719714 · Non-accelerated filer<br>Smaller reporting company

Mereo BioPharma Group plc

Sign in to watch
Ticker
MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
4403330237300
Business address
ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 425 Deal Prospectus/Communication re Business Combination
  3. F-6/A Other F-6/A
  4. F-4 Deal Registration of Securities, Foreign Private Issuers, Business Combinations
  5. 425 Deal Prospectus/Communication re Business Combination
  6. SC 13D Stake Beneficial Ownership Report
  7. 425 Deal Prospectus/Communication re Business Combination
  8. 425 Deal Prospectus/Communication re Business Combination
  9. 425 Deal Prospectus/Communication re Business Combination
  10. 425 Deal Prospectus/Communication re Business Combination
  11. 425 Deal Prospectus/Communication re Business Combination
  12. CERT Other Certification
  13. 8-A12B Other Registration of Securities
  14. F-6/A Other F-6/A
  15. F-1/A Offering Registration Statement for Certain Foreign Private Issuers
  16. F-6 Other Registration of American Depositary Receipt Shares
  17. F-1 Offering Registration Statement for Certain Foreign Private Issuers
  18. DRS/A Other Draft Registration Statement
  19. DRS/A Other Draft Registration Statement
  20. DRS/A Other Draft Registration Statement

Page 22 of 23 · 441 filings